Losing weight slowly on Wegovy — what's normal and what isn't

Why is my weight loss slower than I expected?

Wegovy works partly by reducing appetite and slowing how quickly food leaves your stomach. Those effects take time to build, and the titration schedule (starting at 0.25mg and stepping up roughly every four weeks) is designed for tolerability, not speed. At the early doses your body is adjusting; the appetite suppression at 2.4mg (or 7.2mg for those on the newer higher dose) is measurably stronger than at 0.5mg. Expecting significant loss in the first month or two is setting the bar at the wrong point in the journey.

There's also plain biology. Fat loss requires a calorie deficit, and Wegovy creates that deficit mainly by reducing how much you want to eat. But if calorie intake doesn't actually fall (because stress eating, social meals or habit override the appetite signal) the medicine can't compensate. The factors that shape weight loss on Wegovy are worth reading before drawing conclusions from a few weeks of data.

Sleep, stress and physical activity all affect the rate. Cortisol from poor sleep or chronic stress actively promotes fat retention; strength-based activity preserves muscle while the body sheds fat, which matters for the number on the scales because muscle is denser. None of this is a failure of willpower, it's physiology, and a prescriber can help you untangle what's driving a slow patch.

How slow is too slow, and when does the guidance say to act?

There is a specific clinical threshold, and it isn't vague. NICE's appraisal of semaglutide (TA875) recommends considering whether to continue if less than 5% of body weight has been lost after six months at the maintenance dose. That's the maintenance dose (2.4mg for the standard Wegovy injection) not at whatever dose you happen to be on during titration. Slow weeks during the ramp-up phase don't count toward that six-month clock.

What this means practically: if you're still on 0.5mg or 1.0mg, a slow week is expected. If you've been on 2.4mg for six months and the total loss is under 5%, that's the point your prescriber should review whether continuing makes clinical sense. It's a structured review, not an automatic stop, other factors, such as cardiovascular risk reduction and improved metabolic markers, feed into the decision.

People sometimes check forums midway through titration and conclude the medicine isn't working for them. That's a shame, because the pattern of weight loss on semaglutide genuinely does tend to pick up at higher doses. Cutting treatment short during the adjustment phase misses the window where results are most likely to show.

Could something specific be slowing my progress?

Yes, and several things are worth considering. First: dose. Not everyone tolerates the full titration schedule, some people stay at 1.7mg because 2.4mg produces difficult side effects. That's clinically reasonable, but a lower maintenance dose will generally produce less average weight loss. If side effects have stalled your titration, tell your prescriber rather than staying stuck.

Second: medicines interactions. Some medications (certain antidepressants, steroids, antipsychotics, blood-pressure medicines) are associated with weight gain or make it harder to lose weight. Wegovy doesn't cancel those effects. A prescriber reviewing your full medicine history can flag this.

Third: untreated thyroid problems, insulin resistance, or other metabolic conditions can dampen results. These need investigation, not just a higher Wegovy dose.

Fourth: the eating pattern. Wegovy reduces appetite but doesn't enforce food quality. If hunger is down but ultra-processed, calorie-dense food is still frequent, the deficit may be smaller than expected. The NHS patient information on semaglutide is a solid starting point for what to expect and what to watch for alongside treatment.

If you're weighing yourself daily, measurement noise will look like stalled progress. Hormonal fluctuation, hydration, and when you last ate can shift the reading by 1–2kg without any real change in fat. Weekly weigh-ins, same time, same conditions, give a far more useful picture. A few weeks of slow scales doesn't signal a problem worth acting on.

What actually helps when weight loss on Wegovy slows?

The most useful thing is an honest conversation with a prescriber, before making changes, stopping, or switching. A slow patch on Wegovy sometimes resolves on its own as the dose increases; sometimes it points to something that needs addressing.

Practically, protein intake matters more during treatment than many people realise. Semaglutide reduces overall appetite, which can mean total protein falls along with total calories. Muscle is metabolically active tissue; losing it makes subsequent weight loss harder and makes the number on the scales a less reliable indicator of health progress. Aiming to keep protein adequate (discuss a specific target with your prescriber or a dietitian) is one of the most evidence-consistent things you can do alongside treatment.

Resistance exercise helps preserve muscle for the same reason. You don't need a gym programme; bodyweight exercises done consistently count. Walking more counts too, though it's less effective at preserving lean mass than resistance work.

On the question of cost and commitment: if slow progress is making you wonder whether private treatment is worth continuing, the Wegovy cost context in the UK may help you think through what you're comparing. And if you're considering stopping altogether, it's worth reading about whether you can stop losing weight on Wegovy before that decision is made, weight tends to return without ongoing management, which is why understanding what losing weight after Wegovy involves is a useful part of planning ahead.

It's worth noting that if you're planning a break (holidays in August, or a stretch around payday when re-ordering feels awkward) gaps in treatment can disrupt the progress you've built. Keeping supply consistent, or planning ahead, makes a real difference. If you'd like a prescriber to look at where you are in treatment and what's driving a slow spell, start your free consultation and a GPhC-registered prescriber will review your case the same day.